Omega Funds Closes $438 Million Fund VI Aimed at the Life Sciences

Fifteen-year-old Omega Funds raised $438 million to finance its sixth fund aimed at creating and investing in life sciences companies that target the most urgent medical needs. To date, the investment firm has raised more than $1 billion to invest in drug development companies.